Vyant Bio (VYNT) S-4/A Registration of securities issued in business combination transactions (amended)

Exhibit 99.9

February 8, 2021

Cancer Genetics, Inc.

201 Route 17 North, 2nd Floor

Rutherford, New Jersey

Consent to Reference in Proxy Statement/Prospectus/Information Statement

Cancer Genetics, Inc. (the “Company”) is filing a Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus/information statement included in such registration statement as a future member of the board of directors of the Company.

Sincerely,

/s/ Joanna Horobin

Joanna Horobin